8-K Announcements
6Material company update
May 29, 2026·SEC
Material company update
Apr 29, 2026·SEC
Material company update
Feb 25, 2026·SEC
Vyome Holdings, Inc.(HIND)Earnings, Financials & Key Ratios
HIND•NASDAQ
$2.21
Price updated Jun 27, 2026
AboutVyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.Show more
- Revenue$320K-96.0%
- EBITDA-$3M+64.5%
- Net Income-$10M-43.9%
- EPS (Diluted)-4.75+98.6%
- Gross Margin64.68%+2.4%
- EBITDA Margin-855.47%-788.8%
- Operating Margin-859.22%-790.1%
- Net Margin-3209.75%-3504.1%
- ROE-584.89%-162.9%
HIND Price & Volume
Vyome Holdings, Inc. (HIND) stock price & volume — 10-year historical chart
Loading chart...
Structural Revenue Collapse Threatens Clinical Pipeline Viability
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity exhaustion
Key Thesis Takeaways
- Vyome Holdings faces a precarious outlook as its transition to a pre-revenue clinical entity is marked by a 96% year-over-year revenue decline and persistent operating losses.
- While the MDP platform offers theoretical differentiation in dermatology, the company's inability to scale operations, evidenced by a -35.8% operating margin in 2026Q1, suggests significant execution risk.
- Investors should monitor the critical liquidity position, as the current cash balance of $8.8 million remains insufficient to sustain long-term R&D requirements without further dilutive financing.
Verdict Logic
the company's inability to generate sustainable revenue, combined with a persistent quarterly operating loss of $1.1 million, suggests an imminent risk of liquidity exhaustion.
HIND Growth Metrics
Vyome Holdings, Inc. (HIND) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years0.91%
5 Years-50.98%
3 Years-69.47%
TTM-81.26%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-282.68%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM82.38%
Return on Capital
10 Years-152.5%
5 Years-184.94%
3 Years-218.45%
Last Year-153.89%
HIND Recent Earnings
Vyome Holdings, Inc. (HIND) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (50%)●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
May 12, 2026Metric
Actual
Est
EPS
$0.15+16.7%
$0.18
Rev
—
$32,695
Q2 2026
Mar 26, 2026Metric
Actual
Est
EPS
$0.47+0.0%
$0.47
Rev
$36,551+0.0%
$36,551
Q4 2025
Nov 14, 2025Metric
Actual
Est
EPS
$3.12-2736.4%
$0.11
Rev
$34,627
—
Q3 2025
Aug 14, 2025Metric
Actual
Est
EPS
$2.25
—
Rev
$1M
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.15vs $0.18+16.7% | —vs $32,695 |
| Q2 2026 | Mar 26, 2026 | $0.47vs $0.47+0.0% | $36,551vs $36,551+0.0% |
| Q4 2025 | Nov 14, 2025 | $3.12vs $0.11-2736.4% | $34,627 |
| Q3 2025 | Aug 14, 2025 | $2.25 | $1M |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Vyome Holdings, Inc. (HIND)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.21 | $12.44M | -0.47 | -96.01% | -3209.75% | -584.89% | — | |
| $0.66 | $85.54M | -4.13 | -10.02% | -2.03% | -9.41% | — | |
| $6.62 | $182.19M | -14.09 | 10.2% | -14.82% | -35.57% | — | |
| $5.65 | $1.96B | -9.42 | 698.96% | -102.06% | -44.1% | — | |
| $327.79 | $9.47B | -24.32 | -100% | — | -43.02% | — | |
| $2.80 | $970.56M | 32.83 | 0.57% | 3.74% | 4.75% | — |
Compare HIND vs Peers
Vyome Holdings, Inc. (HIND) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HIND SEC Filings & Documents
Vyome Holdings, Inc. (HIND) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when HIND posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
HIND Frequently Asked Questions
Vyome Holdings, Inc. (HIND) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Vyome Holdings, Inc.'s revenue?
Vyome Holdings, Inc. (HIND) reported $1.3M in revenue for fiscal year 2025.
How fast is Vyome Holdings, Inc. growing?
Vyome Holdings, Inc. (HIND) saw revenue decline by 96.0% over the past year.
Is HIND profitable?
Vyome Holdings, Inc. (HIND) reported a net loss of $13.3M for fiscal year 2025.
Dividend & Returns
What is HIND's return on equity?
Vyome Holdings, Inc. (HIND) has a return on equity (ROE) of -584.9%. Negative ROE indicates the company is unprofitable.
What is Vyome Holdings, Inc.'s free cash flow?
Vyome Holdings, Inc. (HIND) had negative free cash flow of $3.1M in fiscal year 2025, likely due to heavy capital investments.